Showing 1 - 10 results of 10 for search 'John Rotrosen', query time: 0.04s Refine Results
  1. 1
    Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)”

    Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and disco... by Matisyahu Shulman, Roger Weiss, John Rotrosen, Patricia Novo, Elizabeth Costello, Edward V. Nunes

    Published 2021-03-01
    Get full text
    Article
  2. 2
    A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction.

    A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction. by Orna Levran, Matthew Randesi, John Rotrosen, Jurg Ott, Miriam Adelson, Mary Jeanne Kreek

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Under-representation of key demographic groups in opioid use disorder trials

    Under-representation of key demographic groups in opioid use disorder trials by Kara E. Rudolph, Matthew Russell, Sean X. Luo, John Rotrosen, Edward V. Nunes

    Published 2022-09-01
    Get full text
    Article
  4. 4
    A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction.

    A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction. by Orna Levran, Joel Correa da Rosa, Matthew Randesi, John Rotrosen, Miriam Adelson, Mary Jeanne Kreek

    Published 2018-01-01
    Get full text
    Article
  5. 5
    Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment

    Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment by Yue Pan, Daniel J. Feaster, Gabriel Odom, Laura Brandt, Mei-Chen Hu, Roger D. Weiss, John Rotrosen, Andrew J. Saxon, Sean X. Luo, Raymond R. Balise

    Published 2022-12-01
    Get full text
    Article
  6. 6
    Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

    Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized con... by Jing Wang, Lisa V. Doan, Deborah Axelrod, John Rotrosen, Binhuan Wang, Hyung G. Park, Robert R. Edwards, Michele Curatolo, Carina Jackman, Raven Perez, NCATS Trial Innovation Network

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients

    Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care pa... by Jennifer McNeely, Bethany McLeman, Trip Gardner, Noah Nesin, Vijay Amarendran, Sarah Farkas, Aimee Wahle, Seth Pitts, Margaret Kline, Jacquie King, Carmen Rosa, Lisa Marsch, John Rotrosen, Leah Hamilton

    Published 2023-09-01
    Get full text
    Article
  8. 8
    Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

    Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid... by Kathryn Hefner, Tse-Hwei Choo, Dikla Shmueli-Blumberg, Martina Pavlicova, Jacquie King, Marc Fishman, Matisyahu Shulman, Aimee Campbell, Miranda Greiner, Jennifer Scodes, Sarah Meyers-Ohki, Patricia Novo, Edward Nunes, John Rotrosen

    Published 2022-12-01
    Get full text
    Article
  9. 9
    Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff

    Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff by Jennifer McNeely, Pritika C. Kumar, Traci Rieckmann, Erica Sedlander, Sarah Farkas, Christine Chollak, Joseph L. Kannry, Aida Vega, Eva A. Waite, Lauren A. Peccoralo, Richard N. Rosenthal, Dennis McCarty, John Rotrosen

    Published 2018-04-01
    Get full text
    Article
  10. 10
    Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

    Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-si... by Ryan P. McCormack, John Rotrosen, Phoebe Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch, Patricia Novo, David Liu, E. Jennifer Edelman, Sarah Farkas, Abigail G. Matthews, Caroline Mulatya, Dagmar Salazar, Jeremy Wolff, Randolph Knight, William Goodman, Kathryn Hawk

    Published 2021-03-01
    Get full text
    Article

Search Tools: